FDA won’t be hurried to create CBD exceptions amid safety concerns, official says

This article was originally published in MJBizDaily.com A top official for the U.S. Food and Drug Administration (FDA) said the agency is concerned that developing a legal exception for supplements containing CBD could send the wrong message, both to companies interested in entering the market and consumers. Lowell Schiller, the FDA’s principal associate commissioner for…